The 3-Biomarker Classifier-A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with...

Area of Science:

• Oncology
• Molecular Pathology

Background:

• Classical histopathological predictors remain standard for colorectal carcinoma survival prediction.
• Emerging molecular markers offer potential for improved prognostic accuracy.

Purpose of the Study:

• To develop and validate a novel risk score using molecular markers for predicting colorectal carcinoma patient outcomes.
• To assess the utility of a 3-biomarker classifier in stratifying patient risk.

Main Methods:

• Immunohistochemistry on tissue microarrays to detect H2BUB1, RBM3, and Ki-67.
• Categorization of staining intensities to establish a risk score.
• Multivariate analysis and survival curve generation for validation.

Main Results:

• The 3-biomarker classifier was identified as an independent predictor of survival in 1791 evaluated patients.
• A high-risk score strongly correlated with significantly reduced median survival.
• The developed risk score demonstrated prognostic value.

Conclusions:

• The novel risk score can better discriminate between low- and high-risk colorectal carcinoma patients compared to traditional staging.
• This molecular score may guide personalized adjuvant treatment decisions.
• The 3-biomarker classifier serves as a valuable tool for predicting patient outcomes.